C57BL/6NCya-Rmnd5bem1/Cya
Common Name:
Rmnd5b-KO
Product ID:
S-KO-11526
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Rmnd5b-KO
Strain ID
KOCMP-66089-Rmnd5b-B6N-VA
Gene Name
Product ID
S-KO-11526
Gene Alias
0610039K22Rik; Gid2
Background
C57BL/6NCya
NCBI ID
Modification
Conventional knockout
Chromosome
11
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Rmnd5bem1/Cya mice (Catalog S-KO-11526) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000001081
NCBI RefSeq
NM_025346
Target Region
Exon 3~7
Size of Effective Region
~2.4 kb
Detailed Document
Overview of Gene Research
Rmnd5b is a member of the CTLH (carboxy-terminal to LisH) complex, which has E3-ligase enzymatic activity. The CTLH complex is involved in fundamental biological processes like proliferation, survival, programmed cell death, cell adhesion, and migration, and interacts with key signaling pathways such as PI3-kinase, WNT, TGFβ, and NFκB, all of which are crucial for cancer cell plasticity [1].
In esophageal squamous cell carcinoma (ESCC), bioinformatic analysis identified RMND5B as a prognosis-related gene, and a risk-score model based on immune cell-related genes (including RMND5B) was constructed, providing new ideas for ESCC treatment and prognosis studies [2]. In pancreatic adenocarcinoma (PAAD), a ZNF family genes-related risk score model based on 10 genes including RMND5B was established, and the risk score was a significant independent prognostic factor for PAAD patients [3]. Also, in acute myeloid leukemia (AML), a prognostic model containing RMND5B was constructed, which accurately predicted AML prognosis [4].
In conclusion, RMND5B, as part of the CTLH complex, is involved in multiple biological processes related to cancer cell plasticity. Its identification in prognosis-related gene models for ESCC, PAAD, and AML suggests its importance in understanding the prognosis and potentially developing treatment strategies for these cancers.
References:
1. Huffman, Nickelas, Palmieri, Dario, Coppola, Vincenzo. 2019. The CTLH Complex in Cancer Cell Plasticity. In Journal of oncology, 2019, 4216750. doi:10.1155/2019/4216750. https://pubmed.ncbi.nlm.nih.gov/31885576/
2. Wang, Xian, Peng, Wei, Zhao, Yali, Huang, Shan, Wang, Hua. 2024. Immune cell related signature predicts prognosis in esophageal squamous cell carcinoma based on single-cell and bulk-RNA sequencing. In Frontiers in oncology, 14, 1370801. doi:10.3389/fonc.2024.1370801. https://pubmed.ncbi.nlm.nih.gov/38903709/
3. Zhu, Lei, Tu, Dong, Li, Ruixue, Li, Tiehan, Zhu, Hong. 2023. The diagnostic significance of the ZNF gene family in pancreatic cancer: a bioinformatics and experimental study. In Frontiers in genetics, 14, 1089023. doi:10.3389/fgene.2023.1089023. https://pubmed.ncbi.nlm.nih.gov/37396042/
4. Ling, Chun, Cao, Nengneng, Wang, Huiping, Zhang, Qiguo, Zhai, Zhimin. 2025. Systematic Analysis of E3 Ligase-Related Genes Identified UBE2L3 as a Prognostic Biomarker Associated With Drug Resistance in Acute Myeloid Leukemia. In International journal of general medicine, 18, 459-472. doi:10.2147/IJGM.S502644. https://pubmed.ncbi.nlm.nih.gov/39895829/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen